Radiation Therapy on the Objective Response and Outcomes with Nivolumab for Hepatocellular Carcinoma

Radiation Therapy on the Objective Response and Outcomes with Nivolumab for Hepatocellular Carcinoma

User Photo
Mount Sinai Health System

10 months
55 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

William Smith, MD of Mount Sinai describes the effect of radiation therapy on the objective response and outcomes with nivolumab for hepatocellular carcinoma.

________

Among patients with unresectable hepatocellular carcinoma who received combination upfront RT and nivolumab, we found the objective response rate (as determined by mRECIST criteria) to be 35%, substantially increased from historical controls, suggesting that this approach may increase the proportion of patients that would benefit from immune checkpoint inhibition.

Up Next Autoplay